Primary human CD8+ T cells expressing the F29 TCR could mediate cell killing of both CaSki and HNSCC-56 at a range of effector-to-target ratios in vitro (Figure 2, D and E). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.